These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15706257)

  • 41. Letter by Dillinger et al regarding article, "Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin".
    Dillinger JG; Drouet L; Henry P
    Circulation; 2013 Sep; 128(12):e189. PubMed ID: 24043151
    [No Abstract]   [Full Text] [Related]  

  • 42. [Aspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasis].
    Boskholov BP
    Kardiologiia; 2005; 45(7):75-6. PubMed ID: 16091668
    [No Abstract]   [Full Text] [Related]  

  • 43. Some people are resistant to aspirin's protective effects.
    Mayo Clin Health Lett; 2004 Dec; 22(12):4. PubMed ID: 15747414
    [No Abstract]   [Full Text] [Related]  

  • 44. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
    Feher G; Koltai K; Papp E; Alkonyi B; Solyom A; Kenyeres P; Kesmarky G; Czopf L; Toth K
    Drugs Aging; 2006; 23(7):559-67. PubMed ID: 16930084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of obesity on platelet reactivity and response to low-dose aspirin.
    Bordeaux BC; Qayyum R; Yanek LR; Vaidya D; Becker LC; Faraday N; Becker DM
    Prev Cardiol; 2010; 13(2):56-62. PubMed ID: 20377806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin resistance and atherothrombosis.
    Gabriel SA; Beteli CB; Tanighuchi RS; Tristão CK; Gabriel EA; Job JR
    Rev Bras Cir Cardiovasc; 2007; 22(1):96-103. PubMed ID: 17992310
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence of aspirin resistance in stroke patients in Phramongkutklao Hospital.
    Nidhinandana S; Changchit S
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S51-4. PubMed ID: 21280515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is the antiplatelet effect of aspirin affected by systemic inflammation?
    Poulsen TS; Mickley H
    Ann Hematol; 2004 Nov; 83(11):728. PubMed ID: 15338199
    [No Abstract]   [Full Text] [Related]  

  • 49. Aspirin resistance and atherothrombotic disease.
    Maree AO; Jneid H; Fitzgerald DJ
    J Am Coll Cardiol; 2006 Aug; 48(4):846-7; author reply 847. PubMed ID: 16904562
    [No Abstract]   [Full Text] [Related]  

  • 50. Aspirin resistance an underestimated risk in patients with drug-eluting stents?
    Trenk D; Neumann FJ
    J Am Coll Cardiol; 2008 Aug; 52(9):740-2. PubMed ID: 18718421
    [No Abstract]   [Full Text] [Related]  

  • 51. [The concept of aspirin "resistance": mechanisms and clinical relevance].
    Reny JL; Bonvini RF; Barazer I; Berdagué P; de Moerloose P; Schved JF; Gris JC; Fontana P
    Rev Med Interne; 2009 Dec; 30(12):1020-9. PubMed ID: 19595490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients.
    Crescente M; Di Castelnuovo A; Iacoviello L; de Gaetano G; Cerletti C
    Thromb Haemost; 2008 Jun; 99(6):1129-31. PubMed ID: 18521524
    [No Abstract]   [Full Text] [Related]  

  • 53. Aspirin resistance: myth or major problem?
    Grove EL; Hvas AM; Kristensen SD
    Scand J Clin Lab Invest; 2008; 68(4):257-9. PubMed ID: 18612918
    [No Abstract]   [Full Text] [Related]  

  • 54. The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease.
    Cao J; Liu L; Fan L; Chen T; Hu G; Hu Y; Zhu B; Li J; Wang H; Li X
    Aging Male; 2012 Sep; 15(3):140-7. PubMed ID: 22452804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Aspirin resistance theory].
    Porosińska A; Pierzchała K
    Neurol Neurochir Pol; 2006; 40(4):313-9. PubMed ID: 16967353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is arachidonic acid stimulation really a test for the response to aspirin? Time to think again?
    Olechowski B; Ashby A; Mariathas M; Khanna V; Mahmoudi M; Curzen N
    Expert Rev Cardiovasc Ther; 2017 Jan; 15(1):35-46. PubMed ID: 27892731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspirin resistance in cardiovascular disease: a review.
    Wong S; Appleberg M; Ward CM; Lewis DR
    Eur J Vasc Endovasc Surg; 2004 May; 27(5):456-65. PubMed ID: 15079767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of aspirin resistance in patients with type 2 diabetes.
    Fateh-Moghadam S; Plöckinger U; Cabeza N; Htun P; Reuter T; Ersel S; Gawaz M; Dietz R; Bocksch W
    Acta Diabetol; 2005 Jun; 42(2):99-103. PubMed ID: 15944844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impact.
    Papathanasiou A; Goudevenos J; Tselepis AD
    Curr Pharm Des; 2009; 15(10):1085-94. PubMed ID: 19355950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Aspirin resistance].
    Miyata S; Miyata T; Kada A; Nagatsuka K
    Brain Nerve; 2008 Nov; 60(11):1357-64. PubMed ID: 19069170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.